MK-6325

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-6325, covering 2015-02-05 to 2015-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics, and Pharmacodynamics of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003) [Phase 1]

See pricing